Vycor Medical Inc
VYCO· OTC
Quarterly figures for Vycor Medical Inc, with source filings when available.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
Vycor Medical Inc has filed its 10-Q within 39 to 45 days of period end across its last 8 quarters. The 10-K runs 87 to 107 days.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 14, 2026 · after-hours | Aug 14, 2026 | 45 d | 10-Q | $418.26K | −15.7% | $0.00 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 15, 2026 · market hours |
| May 15, 2026 |
| 45 d |
| 10-Q |
| $458.54K |
| +5.1% |
| $0.00 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 31, 2026 · market hours | Mar 31, 2026 | 90 d | 10-K | $416.88K | −8.4% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 · market hours | Nov 14, 2025 | 45 d | 10-Q | $513.79K | +31.5% | $0.00 | |
| Q2 2025 | Jun 30, 2025 | Aug 8, 2025 · market hours | Aug 8, 2025 | 39 d | 10-Q | $496.35K | +22.2% | $0.00 | |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 · market hours | May 15, 2025 | 45 d | 10-Q | $436.38K | +29.5% | -$0.01 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | Apr 15, 2025 | 105 d | 10-K | $455.23K | +47.7% | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 13, 2024 | 44 d | 10-Q | $390.85K | +26.7% | -$0.01 | |
| Q2 2024 | Jun 30, 2024 | — | Aug 13, 2024 | 44 d | 10-Q | $406.28K | −15.8% | $0.00 | |
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | $336.97K | −6.7% | -$0.01 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Apr 16, 2024 | 107 d | 10-K | $308.25K | +13.6% | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | $308.59K | −0.4% | -$0.01 | |
| Q2 2023 | Jun 30, 2023 | — | Aug 11, 2023 | 42 d | 10-Q | $482.77K | +47.2% | $0.00 | |
| Q1 2023 | Mar 31, 2023 | — | May 12, 2023 | 42 d | 10-Q | $360.99K | +15.0% | $0.00 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Apr 14, 2023 | 104 d | 10-K | $271.26K | −0.9% | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | $309.97K | −6.7% | -$0.01 | |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | $327.92K | −33.3% | $0.00 | |
| Q1 2022 | Mar 31, 2022 | — | May 10, 2022 | 40 d | 10-Q | $313.83K | +6.1% | — | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Apr 13, 2022 | 103 d | 10-K | $273.72K | −6.1% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | 43 d | 10-Q | $332.09K | +20.4% | -$0.01 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 16, 2021 | 47 d | 10-Q | $491.43K | +101.2% | $0.00 | |
| Q1 2021 | Mar 31, 2021 | — | May 14, 2021 | 44 d | 10-Q | $295.75K | −10.4% | -$0.01 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 31, 2021 | 90 d | 10-K | $291.62K | −5.1% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 13, 2020 | 44 d | 10-Q | $275.93K | −14.5% | -$0.01 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 17, 2020 | 48 d | 10-Q | $244.27K | −40.7% | -$0.01 | |
| Q1 2020 | Mar 31, 2020 | — | May 12, 2020 | 42 d | 10-Q | $330.24K | −5.8% | -$0.01 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | Mar 27, 2020 | 87 d | 10-K | $307.45K | −27.9% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 12, 2019 | 43 d | 10-Q | $322.88K | −29.2% | -$0.02 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 9, 2019 | 40 d | 10-Q | $411.90K | +36.5% | -$0.01 | |
| Q1 2019 | Mar 31, 2019 | — | May 13, 2019 | 43 d | 10-Q | $350.67K | +7.9% | -$0.01 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | Mar 29, 2019 | 88 d | 10-K | $426.35K | +58.0% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 13, 2018 | 44 d | 10-Q | $456.21K | +20.3% | -$0.01 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 10, 2018 | 41 d | 10-Q | $301.67K | −2.0% | -$0.02 | |
| Q1 2018 | Mar 31, 2018 | — | May 11, 2018 | 41 d | 10-Q | $325.10K | −24.1% | -$0.02 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | Mar 30, 2018 | 89 d | 10-K | $269.82K | −22.3% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 13, 2017 | 44 d | 10-Q | $379.07K | +16.4% | -$0.03 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 11, 2017 | 42 d | 10-Q | $307.68K | −18.9% | -$0.02 | |
| Q1 2017 | Mar 31, 2017 | — | May 11, 2017 | 41 d | 10-Q | $428.40K | +7.1% | -$0.03 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | Mar 31, 2017 | 90 d | 10-K | $347.45K | +23.6% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 14, 2016 | 45 d | 10-Q | $325.78K | +34.1% | -$0.04 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 9, 2016 | 40 d | 10-Q | $379.41K | +32.7% | -$0.03 | |
| Q1 2016 | Mar 31, 2016 | — | Apr 28, 2016 | 28 d | 10-Q | $400.09K | +21.8% | -$0.06 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | Mar 30, 2016 | 90 d | 10-K | $281.20K | +8.4% | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 13, 2015 | 44 d | 10-Q | $242.86K | −27.4% | -$0.05 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 14, 2015 | 45 d | 10-Q | $286.02K | −4.2% | -$0.04 | |
| Q1 2015 | Mar 31, 2015 | — | May 15, 2015 | 45 d | 10-Q | $328.55K | −8.3% | -$0.07 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | Mar 31, 2015 | 90 d | 10-K | $259.29K | −13.9% | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 12, 2014 | 43 d | 10-Q | $334.34K | +4.0% | -$0.12 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 12, 2014 | 43 d | 10-Q | $298.54K | +27.1% | -$0.12 | |
| Q1 2014 | Mar 31, 2014 | — | May 15, 2014 | 45 d | 10-Q | $358.12K | +54.6% | -$0.09 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | Apr 7, 2014 | 97 d | 10-K | $301.12K | +4.9% | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 15, 2013 | 46 d | 10-Q | $321.63K | +46.1% | -$0.08 | |
| Q2 2013 | Jun 30, 2013 | — | Aug 14, 2013 | 45 d | 10-Q | $234.95K | −11.5% | -$0.10 | |
| Q1 2013 | Mar 31, 2013 | — | May 15, 2013 | 45 d | 10-Q | $231.67K | −46.4% | -$0.11 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | Apr 1, 2013 | 91 d | 10-K | $287.16K | −36.6% | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 14, 2012 | 45 d | 10-Q | $220.12K | −4.8% | -$0.14 | |
| Q2 2012 | Jun 30, 2012 | — | Aug 14, 2012 | 45 d | 10-Q | $265.39K | +86.5% | -$0.14 | |
| Q1 2012 | Mar 31, 2012 | — | May 15, 2012 | 45 d | 10-Q | $432.60K | +198.1% | -$0.14 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Dec 31, 2011 | — | Mar 30, 2012 | 90 d | 10-K | $452.64K | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 14, 2011 | 45 d | 10-Q | $231.28K | +224.8% | $0.00 | |
| Q2 2011 | Jun 30, 2011 | — | Aug 22, 2011 | 53 d | 10-Q | $142.33K | +90.2% | -$0.00 | |
| Q1 2011 | Mar 31, 2011 | — | May 13, 2011 | 43 d | 10-Q | $145.12K | — | -$0.00 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | Mar 31, 2011 | 90 d | 10-K | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 15, 2010 | 46 d | 10-Q | $71.21K | — | -$0.00 | |
| Q2 2010 | Jun 30, 2010 | — | Aug 16, 2010 | 47 d | 10-Q | $74.82K | — | -$0.00 | |